Vancomycin Hydrochloride — Drug Intelligence | 11 EU Trials

Filter these 11 trials by condition, phase, country and more.

Open in Search →

11 Registered trials

5 Recruiting

2 Completed trials

9 Sponsors

12 Countries

Phase III

Phase II

Phase IV

Phase III: 4 Phase II: 5 Phase IV: 2

Indications tested

Colitis ulcerative 1

Sponsors using this IMP

Pirkanmaan hyvinvointialue 3 Assistance Publique Hopitaux De Paris 1 Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura A Carattere Scientifico 1 Centre Hospitalier Universitaire De Nantes 1 Fakultni Nemocnice Bulovka 1 Hvidovre Hospital 1 Turku University Hospital 1 Universitaetsklinikum Heidelberg AöR 1 Vedanta Biosciences Inc. 1

All trials

11 total

Rifampin-free regimen versus rifampin-containing regimen in the treatment of staphylococcal prosthetic valve endocarditis: a multicenter ran… Pending

2024-518018-22-00 Phase III 1 country Centre Hospitalier Universitaire De Nantes
Continuous antibiotic infusion in children Pending

2025-522809-38-00 Phase III 1 country Pirkanmaan hyvinvointialue
The efficacy of oral vancomycin therapy in managing different phenotypes of paediatric inflammatory bowel diseases by correlating treatment … Pending

2025-524543-12-00 Phase II 1 country Pirkanmaan hyvinvointialue
LIBRETTO: Stimulan™ Local Antibiotic Delivery System Versus 4-Week Systemic Antibiotic Therapy for Diabetic Foot Osteomyelitis – A Prospecti… Pending

2025-524723-52-00 Phase III 1 country Pirkanmaan hyvinvointialue
Fecal Microbiota Transplantation to RESCUE patients with unresectable Hcc progressors to first line therapy with AtezolizUmaB and Bevacizuma… Recruiting

2023-510504-45-00 Phase II 1 country Azienda Ospedaliero-Universitaria Di Bologna IRCCS Istituto Di Ricerca E Di Cura…
ANtibiotic TReatment OPtimisation – randomised controlled trial of Clostridioides difficile infection therapy (ANTROP-I) Recruiting

2024-518607-21-00 Phase II 1 country Fakultni Nemocnice Bulovka
Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab – A randomized, placebo-controlled, double-blin… Recruiting

2023-506887-15-00 Phase II 1 country Universitaetsklinikum Heidelberg AöR
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, no… Recruiting

2024-519186-21-01 Phase IV 1 country Hvidovre Hospital
Linezolid or vancomycin surgical site infection prophylaxis LOVip Recruiting

2023-504986-22-00 Phase III 1 country Assistance Publique Hopitaux De Marseille
Vancomycin treatment in critically ill adults using model-informed precision dosing tool – prospective low-intervention clinical trial. (Pro… Ended

2023-509003-32-00 Phase IV 1 country Tartu University Hospital
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of VE202 in Patients with Mild-to-Moderate Ulcerative Colitis Ended

2024-512558-40-00 Phase II 6 countries Vedanta Biosciences Inc.

Showing 1–11 of 11 trials

← All drugs A–Z